Health Canada approves the use of Pfizer's anti-COVID-19 viral drug Paxlovid for people over the age of 18 years who are at risk of severe disease and death. (CBC) COVID-19 pandemic in Canada, COVID-19 drug developmentCOVID-19 pandemic link embed save